![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 30, 2020 9:47:49 AM
Ignore the short-term noise in the sector and buy OGI stock for long-term success
By Ian Cooper Jan 30, 2020, 5:01 am EST
https://investorplace.com/2020/01/organigram-stock-a-standout-long-term-winner-in-the-cannabis-sector/
Having survived a tough year, investors in cannabis stocks are taking a long, hard look at what 2020 portends. Supply concerns, warnings, and a host of poor earnings were devastating to names like Canopy Growth (NYSE:CGC), Aurora Cannabis (NYSE:ACB), Cronos Group (NASDAQ:CRON) and Horizons Marijuana Life Sciences Index ETF (OTCMKTS:HMLSF).
However, there’s plenty of opportunity to be found in down-and-out cannabis stocks.
For one, support for U.S. legalization is explosive. According to Pew Research Center, 67% of Americans now support its legalization with only 32% of adults now opposing. A Gallup survey found a similar number in favor.
In response, more states are legalizing recreational use, with Illinois just the latest of a growing list. That sort of action in state capitals is contributing to what Arcview Market Research and BDS Analytics say will create global pot spending of $57 billion over the next decade. With the growing talk on presidential campaign trails of federal legalization as a platform plank, we could see higher highs for the sector.
While this all could create the rising tide to lift all ships, over time, I believe one of the top winners in the space will be Organigram Holdings (NYSE:OGI).
In fact, from a current price of about $2.70, I wouldn’t be shocked if we see $10 with patience.
Emerging as a Long-Term Winner
One of the most compelling reasons to own OGI stock is the fact it’s a major grower with the ability to produce peak annual output of 100,000 kilos. Better, its cannabis output comes from its Monkton facility. Having just one campus reduces supply chain costs, as noted by Motley Fool contributor Sean Williams.
Also, OGI has no financing concerns. In fact, the company believes it has enough capital to fund operations and planned capital expenditures. It had $34.1 million of cash and short-term investments at the end of the quarter, in addition to $30 million in undrawn capacity.
Better, OGI could see further upside with the Canadian market well-positioned for retail growth. Retail sales are planned for Ontario and Quebec, which represent 60% of the Canadian population. The recent legalization of edibles and derivatives — so-called Cannabis 2.0 — will be another strong catalyst.
Earnings “Surprisingly Encouraging”
To be sure, CEO Greg Engel recently said, “I still think we’re not going to hit any sense of normalcy or predictability until the fourth quarter of this year,” pointing to the launch of the edible and vaping segment of the market, which was just made legal in October.”
However, its numbers have been solid. The company knocked fiscal 2020 Q1 earnings out of the park, doubling net revenue growth to 25.2 million CAD ($19.3 million) year over year. That beat estimates for 21 million CAD. OGI also returned to positive EBITDA for the quarter.
“Despite ongoing industry challenges, we are pleased with solid Q1 2020 results and our return to positive adjusted EBITDA during the quarter, said Engel. “Our team was also successful in shipping the first of our Rec 2.0 products as planned and on schedule in December of 2019. We also look forward to the launch of the remainder of our vape pen portfolio followed soon after by our premium cannabis-infused chocolate products. In addition to an exciting line-up of 2.0 products, we are rolling out a couple of new core strains, such as our high THC Edison Limelight, across the country following their success as limited-time-offers in smaller markets.”
Analysts were impressed. Jefferies analyst Owen Bennett noted it’s a “return to the Organigram of old.” CIBC analysts also said the numbers were “surprisingly encouraging.”
Bottom Line on Organigram Stock
With plenty of demand and legalization efforts, the long-term growth story is still very much intact with Organigram stock. With great earnings, the fact it’s a major grower, and Canadian growth, OGI stock is high on the list of top cannabis stocks to buy and hold, long-term.
As of this writing, Ian Cooper did not hold a position in any of the aforementioned securities.
Recent OGI News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/13/2024 11:25:59 AM
- Organigram Reports Third Quarter Fiscal 2024 Results • Business Wire • 08/13/2024 10:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 03:19:22 PM
- Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology • Business Wire • 08/07/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/06/2024 02:32:27 PM
- Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024 • Business Wire • 08/06/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2024 03:20:28 PM
- Organigram Announces Appointment of Craig Harris to Board of Directors • Business Wire • 07/29/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/24/2024 09:06:57 PM
- Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos • Business Wire • 07/24/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/12/2024 07:13:48 PM
- Organigram investiert in Sanity Group, ein führendes deutsches Cannabisunternehmen • Business Wire • 06/26/2024 01:15:00 PM
- Organigram investe in Sanity Group, società leader tedesca nel settore della cannabis • Business Wire • 06/26/2024 01:15:00 PM
- Organigram investit dans Sanity Group, un chef de file du cannabis en Allemagne • Business Wire • 06/26/2024 01:15:00 PM
- Organigram Invests in Sanity Group, a Leading German Cannabis Company • Business Wire • 06/25/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/28/2024 01:38:30 PM
- Organigram Signs Three Year Supply Agreement with Avida Medical in UK • Business Wire • 05/28/2024 10:00:00 AM
- US Futures Remain Steady Amid Wall Street Caution Ahead of April PPI Report • IH Market News • 05/14/2024 11:18:01 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2024 11:17:16 AM
- Organigram Reports Second Quarter Fiscal 2024 Results • Business Wire • 05/14/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/08/2024 03:29:51 PM
- Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024 • Business Wire • 05/08/2024 12:00:00 PM
- Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year • Business Wire • 04/08/2024 10:00:00 AM
- Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales • Business Wire • 04/03/2024 12:06:00 PM
- Organigram Successfully Closes Previously Announced Underwritten Public Offering • Business Wire • 04/02/2024 12:51:00 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM